Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Andrade, Bruno B ^a,b   Reis Filho, Antonio ^a,b   Souza Neto, Sebastio M ^a,b   Clarncio, Jorge ^a,b   Camargo, Luis Ma ^c,d   Barral, Aldina ^a,b,e   Barral Netto, Manoel ^a,b,e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Faculdade Sao Lucas   (Brazil)

^e Instituto Nacional de Ciencia e Tecnologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADOLESCENT; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAZIL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDEMIC DISEASE; FEMALE; HUMAN; INFLAMMATION; LABORATORY TEST; MALARIA FALCIPARUM; MALE; MICROSCOPY; PATHOPHYSIOLOGY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; SCHOOL CHILD; AGE; AGED; BLOOD; FLOW CYTOMETRY; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIMALARIALS; BRAZIL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77649284273     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-13     Document Type: Article

References (32)

1. The pathophysiology of vivax malaria. NM Anstey B Russell TW Yeo RN Price, Trends Parasitol 2009 25 220 227 10.1016/j.pt.2009.02.003 19349210
2. Vivax malaria: neglected and not benign. RN Price E Tjitra CA Guerra S Yeung NJ White NM Anstey, Am J Trop Med Hyg 2007 77 79 87 18165478
3. National System in Health Surveillance: situation report: Rondnia. J da Silva Jr, Brasília: Ministério da Sade 2006 24
4. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. FP Alves RR Durlacher MJ Menezes H Krieger LH Silva EP Camargo, Am J Trop Med Hyg 2002 66 641 648 12224567
5. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. S Ladeia-Andrade MU Ferreira ME de Carvalho I Curado JR Coura, Am J Trop Med Hyg 2009 80 452 459 19270298
6. Hepatic dysfunction in a patient with Plasmodium vivax infection. A Nautiyal S Singh G Parmeswaran M DiSalle, Med Gen Med 2005 7 8
7. Acute renal failure in Plasmodium vivax malaria. J Prakash AK Singh NS Kumar RK Saxena, J Assoc Physicians India 2003 51 265 267 12839348
8. Sepsis due to extended-spectrum beta-lactamase-producing Aeromonas hydrophila in a pediatric patient with diarrhea and pneumonia. CN Rodriguez R Campos B Pastran I Jimenez A Garcia P Meijomil AJ Rodriguez-Morales, Clin Infect Dis 2005 41 421 422 10.1086/431773 16007554
9. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. MJ Barcus H Basri H Picarima C Manyakori Sekartuti I Elyazar MJ Bangs JD Maguire JK Baird, Am J Trop Med Hyg 2007 77 984 991 17984364
10. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. B Genton V D'Acremont L Rare K Baea JC Reeder MP Alpers I Muller, PLoS Med 2008 5 127 10.1371/journal.pmed.0050127 18563961
11. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. E Tjitra NM Anstey P Sugiarto N Warikar E Kenangalem M Karyana DA Lampah RN Price, PLoS Med 2008 5 128 10.1371/journal.pmed.0050128 18563962
12. [Plasmodium vivax malaria in the Brazilian Amazon: some aspects of its epidemiology, clinical spectrum and naturally induced immune responses]. CT Daniel-Ribeiro MV Lacerda J Oliveira-Ferreira, Bull Soc Pathol Exot 2008 101 243 248 18683322
13. Plasmodium vivax malaria presenting with severe thrombocytopenia. RP Makkar S Mukhopadhyay A Monga AK Gupta, Braz J Infect Dis 2002 6 263 265 10.1590/S1413-86702002000500008 12495609
14. Occurrence of thrombocytopenia in Plasmodium vivax malaria. AJ Rodriguez-Morales E Sanchez M Vargas C Piccolo R Colina M Arria C Franco-Paredes, Clin Infect Dis 2005 41 130 131 10.1086/430837 15937782
15. Cerebral involvement in benign tertian malaria. MA Beg R Khan SM Baig Z Gulzar R Hussain RA Smego Jr, Am J Trop Med Hyg 2002 67 230 232 12408660
16. Cerebral malaria owing to Plasmodium vivax: case report. M Ozen S Gungor M Atambay N Daldal, Ann Trop Paediatr 2006 26 141 144 10.1179/146532806X107494 16709334
17. Renal failure in malaria. BS Das, J Vector Borne Dis 2008 45 83 97 18592837
18. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. NM Anstey T Handojo MC Pain E Kenangalem E Tjitra RN Price GP Maguire, J Infect Dis 2007 195 589 596 10.1086/510756 17230420
19. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. MA Tanios L Kogelman B McGovern PM Hassoun, Crit Care Med 2001 29 665 667 10.1097/00003246-200103000-00037 11373440
20. Blood coagulation, inflammation, and malaria. IM Francischetti KB Seydel RQ Monteiro, Microcirculation 2008 15 81 107 10.1080/10739680701451516 18260002
21. Human malarial disease: a consequence of inflammatory cytokine release. IA Clark AC Budd LM Alleva WB Cowden, Malar J 2006 5 85 10.1186/1475-2875-5-85 17029647
22. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. NP Day TT Hien T Schollaardt PP Loc LV Chuong TT Chau NT Mai NH Phu DX Sinh NJ White M Ho, J Infect Dis 1999 180 1288 1297 10.1086/315016 10479160
23. Spatial analysis and determination of malaria control areas in the State of Rondonia. F Rodrigues Ade AL Escobar R Souza-Santos, Rev Soc Bras Med Trop 2008 41 55 64 18368272
24. How prevalent is Plasmodium malariae in Rondonia, western Brazilian Amazon? MT Cavasini WL Ribeiro F Kawamoto MU Ferreira, Rev Soc Bras Med Trop 2000 33 489 492 10.1590/S0037-86822000000500011 11064586
25. Severe falciparum malaria. WHO, Trans R Soc Trop Med Hyg 2000 94 1 90 10748883
26. Detection and identification of the four malaria parasite species infecting humans by PCR amplification. G Snounou, Methods Mol Biol 1996 50 263 291 8751365
27. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. G Snounou S Viriyakosol XP Zhu W Jarra L Pinheiro VE do Rosario S Thaithong KN Brown, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
28. Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. BB Andrade BC Rocha A Reis-Filho LM Camargo WP Tadei LA Moreira A Barral M Barral-Netto, Malar J 2009 8 121 10.1186/1475-2875-8-121 19500362
29. Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. NC Iriemenam CM Okafor HA Balogun I Ayede Y Omosun JO Persson M Hagstedt CI Anumudu RI Nwuba M Troye-Blomberg K Berzins, Afr Health Sci 2009 9 66 74 19652739
30. The paroxysm of Plasmodium vivax malaria. ND Karunaweera SK Wijesekera D Wanasekera KN Mendis R Carter, Trends Parasitol 2003 19 188 193 10.1016/S1471-4922(03)00036-9 12689650
31. Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. MC D'Ombrain LJ Robinson DI Stanisic J Taraika N Bernard P Michon I Mueller L Schofield, Clin Infect Dis 2008 47 1380 1387 10.1086/592971 18947328
32. Cytokines and clinical manifestations of malaria in adults with severe and uncomplicated disease. A Wroczynska W Nahorski A Bakowska H Pietkiewicz, Int Marit Health 2005 56 103 114 16532589